Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 N Saint Clair St
Suite 19-100
Chicago, IL 60611Phone+1 312-695-4965
Summary
- HFpEF, cardiac amyloid, pulmonary hypertension, clinical trials, clinical physiologic studies (deep phenotyping), machine learning, precision therapeutics
Education & Training
- University of ChicagoFellowship, Cardiovascular Disease, 2006 - 2007
- University of California (San Francisco)Fellowship, Cardiovascular Disease, 2004 - 2006
- University of California (San Francisco)Residency, Internal Medicine, 2000 - 2003
- Northwestern University The Feinberg School of MedicineClass of 2000
Certifications & Licensure
- CA State Medical License 2002 - Present
- FL State Medical License 2024 - Present
- IL State Medical License 2006 - 2026
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Ranolazine and Pulmonary Hypertension Start of enrollment: 2010 Jun 01
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial Start of enrollment: 2011 Sep 15
- Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction Start of enrollment: 2014 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 523 citationsSpironolactone for heart failure with preserved ejection fraction.Bertram Pitt, Marc A Pfeffer, Susan F Assmann, Robin Boineau, Inder S Anand
The New England Journal of Medicine. 2014-04-10 - 189 citationsPrevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fractionVenkatesh Y. Anjan, Timothy M. Loftus, Michael A. Burke, Nausheen Akhter, Gregg C. Fonarow
The American Journal of Cardiology. 2012-09-15 - 226 citationsA Test in Context: E/A and E/e′ to Assess Diastolic Dysfunction and LV Filling PressureSumeet S. Mitter, Sanjiv J. Shah, James D. Thomas
Journal of the American College of Cardiology. 2017-03-21
Journal Articles
- Clinical Research Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients with Preserved Ejection FractionSanjiv J Shah, Dalane W Kitzman, Barry A Borlaug, Daniel Burkhoff, ScienceDirect
- Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients with Heart Failure with Preserved Ejection FractionGregory D Lewis, David J Whellan, Martin M LeWinter, Margaret M Redfield, Andrew L Smith, Eugene Braunwald, Michael M Givertz, Adrian F Hernandez, Sanjiv J Shah, Horng..., JAMA
- Clinical Research History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart FailureJaved Butler, Margaret M Redfield, Adrian F Hernandez, Muthiah Vaduganathan, Ravi B Patel, Sanjiv J Shah, ScienceDirect
- Join now to see all
Lectures
- CorviaCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/12/2019
- Corvia for HFpEF (REDUCE LAP II)CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/14/2019
- Iatrogenic ASD Devices for Heart Failure: Proof of Principle and Potential Impact on Patient Care2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Join now to see all
Press Mentions
- SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients with ObesityNovember 16th, 2024
- Mavacamten Shows Promise in Heart Failure with Normal to Supranormal EFSeptember 30th, 2024
- Weight Loss Drug Shows Benefits for Heart FailureMay 8th, 2024
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: